Company · CIK 0001326205 · SIC 2834 — Pharmaceutical Preparations · NYSE
IGC Pharma, Inc. · IGC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 AForm 4 → | Jul 1, 9:01 am EDT | Ram MukundaCEO, Director | 2,226,475 | $0.27 | $601,148 | 6,875,563 | — | |
| Jun 30, 2026 AForm 4 → | Jul 1, 9:00 am EDT | Claudia GrimaldiPFO, Director | 2,048,378 | $0.27 | $553,062 | 3,421,092 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.